Christopher Freeman
Equibles does not estimate personal net worth.
Get an email with a short summary when Guardant Health, Inc. publishes a filing, an earnings call transcript or a press release.
Get GH alertsAbout Christopher Freeman
The proxy statement of Guardant Health, Inc. reports total compensation of $3,523,052 for Christopher Freeman in fiscal 2023, including a base salary of $490,385. Disclosed compensation is on record for 3 fiscal years. Guardant Health, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Guardant Health, Inc. includes AmirAli Talasaz (CEO and Board Member), Helmy Eltoukhy (CEO, Chairman and Board Member), Michael Bell (CFO) and 7 others.
Affiliation history
-
Guardant Health, Inc. (GH)
Proxy statement
CurrentStart not stated–present
Last confirmed April 28, 2026
Company network
Leadership on record at Guardant Health, Inc.
- AmirAli Talasaz CEO, Board Member
- Helmy Eltoukhy CEO, Chairman, Board Member
- Michael Bell CFO
- Ines Dahne-Steuber COO
- Darya Chudova CTO
- Kumud Kalia CIO
- John Saia General Counsel
- Robert A. Parks Chief Accounting Officer
- Alex M. Azar II Board Member
- Ian Clark Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Guardant Health, Inc. (GH) | Chief Commercial Officer | $490,385 | $3,523,052 |
| 2022 | Guardant Health, Inc. (GH) | Chief Commercial Officer | $468,269 | $3,969,567 |
| 2021 | Guardant Health, Inc. (GH) | Chief Commercial Officer | $249,231 | $5,436,449 |
Recent activity
No call appearances or filed executive changes recorded yet.